EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Shifting cold to hot tumors by nanoparticle-loaded drugs and products

Irfan Ahmad, Kamil K Atiyah Altameemi, Mohaned Mohammed Hani, Afaq Mahdi Ali, Hasanain Khaleel Shareef, Zahraa F Hassan, Mahmood Hasen Shuhata Alubiady, Salah Hassan Zain Al-Abdeen, Hussein Ghafel Shakier, Ahmed Huseen Redhee

Clinical and Translational Oncology · 2024

DOI: 10.1007/s12094-024-03577-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Irfan Ahmad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia. erfanahmadmedu@gmail.com. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 325 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cold tumors lack antitumor immunity and are resistant to therapy, representing a major challenge in cancer medicine. Because of the immunosuppressive spirit of the tumor microenvironment (TME), this form of tumor has a low response to immunotherapy, radiotherapy, and also chemotherapy. Cold tumors have low infiltration of immune cells and a high expression of co-inhibitory molecules, such as immune checkpoints and immunosuppressive molecules. Therefore, targeting TME and remodeling immunity in cold tumors can improve the chance of tumor repression after therapy. However, tumor stroma prevents the infiltration of inflammatory cells and hinders the penetration of diverse molecules and drugs. Nanoparticles are an intriguing tool for the delivery of immune modulatory agents and shifting cold to hot tumors. In this review article, we discuss the mechanisms underlying the ability of nanoparticles loaded with different drugs and products to modulate TME and enhance immune cell infiltration. We also focus on newest progresses in the design and development of nanoparticle-based strategies for changing cold to hot tumors. These include the use of nanoparticles for targeted delivery of immunomodulatory agents, such as cytokines, small molecules, and checkpoint inhibitors, and for co-delivery of chemotherapy drugs and immunomodulatory agents. Furthermore, we discuss the potential of nanoparticles for enhancing the efficacy of cancer vaccines and cell therapy for overcoming resistance to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsNanoparticlesAntineoplastic AgentsNanoparticle Drug Delivery SystemHumansDrug Delivery SystemsAnimalsCancer VaccinesImmunotherapyImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

Cold tumorImmune checkpointsImmunotherapyNanoparticlesTumor microenvironment

Substanzen

Antineoplastic AgentsCancer VaccinesImmune Checkpoint InhibitorsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia. erfanahmadmedu@gmail.com.
  • Faculty of Pharmacy, Department of Pharmaceutics, University of Al-Ameed, Karbala, Iraq.
  • Department of Medical Instrumentation Engineering Techniques, Imam Ja'afar Al-Sadiq University, Al Muthanna, Iraq.
  • Department of Pharmaceutics, Al-Turath University College, Baghdad, Iraq.
  • Department of Medical Biotechnology, College of Science, Al-Mustaqbal University, Hilla, Iraq.
  • Biology Department, College of Science for Women, University of Babylon, Hilla, Iraq.

Zitieren

APA

Ahmad, I., Altameemi, K. K. A., Hani, M. M., Ali, A. M., Shareef, H. K., Hassan, Z. F., Alubiady, M. H. S., Al-Abdeen, S. H. Z., Shakier, H. G., & Redhee, A. H. (2024). Shifting cold to hot tumors by nanoparticle-loaded drugs and products. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03577-3

Vancouver

Ahmad I, Altameemi KKA, Hani MM, Ali AM, Shareef HK, Hassan ZF, et al. Shifting cold to hot tumors by nanoparticle-loaded drugs and products. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03577-3

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Irfan and Altameemi, Kamil K Atiyah and Hani, Mohaned Mohammed and Ali, Afaq Mahdi and Shareef, Hasanain Khaleel and Hassan, Zahraa F and Alubiady, Mahmood Hasen Shuhata and Al-Abdeen, Salah Hassan Zain and Shakier, Hussein Ghafel and Redhee, Ahmed Huseen},
  title = {Shifting cold to hot tumors by nanoparticle-loaded drugs and products},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  doi = {10.1007/s12094-024-03577-3}
}
Kostenlos starten →